New Insights into the LANCL2-ABA Binding Mode towards the Evaluation of New LANCL Agonists

脱落酸 背景(考古学) 神经保护 化学 兴奋剂 生物化学 药理学 细胞生物学 生物 受体 古生物学 基因
作者
Naomi Scarano,Francesco Di Palma,Nicola Origlia,Francesca Musumeci,Silvia Schenone,Sonia Spinelli,Mario Passalacqua,Elena Zocchi,Laura Sturla,Elena Cichero,Andrea Cavalli
出处
期刊:Pharmaceutics [Multidisciplinary Digital Publishing Institute]
卷期号:15 (12): 2754-2754 被引量:3
标识
DOI:10.3390/pharmaceutics15122754
摘要

The lanthionine synthetase C-like (LANCL) proteins include LANCL2, which is expressed in the central nervous system (CNS) and in peripheral tissues. LANCL2 exhibits glutathionylation activity and is involved in the neutralization of reactive electrophiles. Several studies explored LANCL2 activation as a validated pharmacological target for diabetes and inflammatory bowel disease. In this context, LANCL2 was found to bind the natural product abscisic acid (ABA), whose pre-clinical effectiveness in different inflammatory diseases was reported in the literature. More recently, LANCL2 attracted more attention as a valuable resource in the field of neurodegenerative disorders. ABA was found to regulate neuro-inflammation and synaptic plasticity to enhance learning and memory, exhibiting promising neuroprotective effects. Up until now, a limited number of LANCL2 ligands are known; among them, BT-11 is the only compound patented and investigated for its anti-inflammatory properties. To guide the design of novel putative LANCL2 agonists, a computational study including molecular docking and long molecular dynamic (MD) simulations of both ABA and BT-11 was carried out. The results pointed out the main LANCL2 ligand chemical features towards the following virtual screening of a novel putative LANCL2 agonist (AR-42). Biochemical assays on rat H9c2 cardiomyocytes showed a similar, LANCL2-mediated stimulation by BT-11 and by AR-42 of the mitochondrial proton gradient and of the transcriptional activation of the AMPK/PGC-1α/Sirt1 axis, the master regulator of mitochondrial function, effects that are previously observed with ABA. These results may allow the development of LANCL2 agonists for the treatment of mitochondrial dysfunction, a common feature of chronic and degenerative diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
善学以致用应助KK采纳,获得10
刚刚
黑桃Q发布了新的文献求助10
刚刚
1秒前
FashionBoy应助认真初之采纳,获得10
4秒前
吴子鹏完成签到,获得积分10
4秒前
风清扬应助范范采纳,获得10
5秒前
茹茹完成签到,获得积分10
5秒前
6秒前
xzby发布了新的文献求助10
6秒前
陶醉世德完成签到,获得积分10
6秒前
猪猪hero应助清神安采纳,获得10
7秒前
8秒前
Rondab应助幸福大白采纳,获得30
9秒前
孙福禄应助LEOhard采纳,获得10
10秒前
enchanted完成签到,获得积分10
14秒前
FashionBoy应助机智的水风采纳,获得10
14秒前
忐忑的麦片完成签到,获得积分10
15秒前
852应助Liolsy采纳,获得10
15秒前
如此这般关注了科研通微信公众号
16秒前
爆米花应助Zhou采纳,获得10
16秒前
汤成莉完成签到 ,获得积分10
16秒前
Rondab应助幸福大白采纳,获得30
17秒前
科目三应助陈曦采纳,获得10
18秒前
大鱼应助好好好采纳,获得10
18秒前
enchanted发布了新的文献求助10
18秒前
19秒前
19秒前
21秒前
22秒前
小鼠星球完成签到,获得积分20
22秒前
黑桃Q完成签到,获得积分10
23秒前
24秒前
24秒前
25秒前
传奇3应助surong采纳,获得10
26秒前
26秒前
英姑应助Georges-09采纳,获得10
27秒前
研友_VZG7GZ应助会飞的扁担采纳,获得10
27秒前
火柴盒发布了新的文献求助10
28秒前
比利时光完成签到,获得积分10
28秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989510
求助须知:如何正确求助?哪些是违规求助? 3531756
关于积分的说明 11254536
捐赠科研通 3270255
什么是DOI,文献DOI怎么找? 1804947
邀请新用户注册赠送积分活动 882113
科研通“疑难数据库(出版商)”最低求助积分说明 809176